Steve Wilton (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Steve Wilton" in English language version.

refsWebsite

Global rank English rank

6murdoch.edu.au

6,278^th place

3,907^th place

4perroninstitute.org

low place

low place

2^nd place

2^nd place

4^th place

4^th place

low place

low place

610^th place

704^th place

7,226^th place

4,917^th place

2thewest.com.au

3,165^th place

1,780^th place

2businessnews.com.au

low place

low place

low place

9,141^st place

234^th place

397^th place

2,393^rd place

3,174^th place

1blackswan-pharma.com

low place

low place

1australian.museum

low place

6,629^th place

1rotarywestperth.org.au

low place

low place

1adelaide.edu.au

3,827^th place

2,887^th place

low place

low place

1rotarymastertonsouth.club

low place

low place

1fshdglobal.org

low place

low place

1bizjournals.com

407^th place

241^st place

1scholar.google.com

1,697^th place

1,040^th place

1musculardystrophynews.com

low place

low place

139^th place

108^th place

low place

low place

1sciencedirect.com

149^th place

178^th place

485^th place

440^th place

low place

low place

aahms.org

"Professor Steve Wilton". Australian Academy of Health and Medical Sciences. 2024-10-24. Retrieved 2024-10-25.

abc.net.au

"Duchenne muscular dystrophy drug developed by Perth researchers approved by FDA". ABC News. September 20, 2016 – via www.abc.net.au.

adelaide.edu.au

digital.library.adelaide.edu.au

"The Case of Bresagen" (PDF).

agcts.org.au

australian.museum

"2013 Australian Museum Eureka Prizes winners". The Australian Museum.

bizjournals.com

"The 20-year road to make the world's first exon-skipping drug".

blackswan-pharma.com

"Company".

businessnews.com.au

"Steve Wilton". Business News.
"Perron Institute partners in Asia". 28 November 2017.

doi.org

Cale, Jessica M.; Greer, Kane; Fletcher, Sue; Wilton, Steve D. (January 3, 2021). "Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52". International Journal of Molecular Sciences. 22 (7): 3479. doi:10.3390/ijms22073479. PMC 8037683.
Li, Dunhui; Aung-Htut, May T.; Ham, Kristin A.; Fletcher, Sue; Wilton, Steve D. (January 3, 2020). "A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations". International Journal of Molecular Sciences. 21 (19): 7282. doi:10.3390/ijms21197282. PMC 7582384. PMID 33019779.
Lu, Qi Long; Mann, Christopher J.; Lou, Fang; Bou-Gharios, George; Morris, Glenn E.; Xue, Shao-an; Fletcher, Sue; Partridge, Terence A.; Wilton, Stephen D. (August 3, 2003). "Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse". Nature Medicine. 9 (8): 1009–1014. doi:10.1038/nm897 – via www.nature.com.
Alter, Julia; Lou, Fang; Rabinowitz, Adam; Yin, HaiFang; Rosenfeld, Jeffrey; Wilton, Steve D.; Partridge, Terence A.; Lu, Qi Long (February 3, 2006). "Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology". Nature Medicine. 12 (2): 175–177. doi:10.1038/nm1345. PMID 16444267 – via www.nature.com.

elsevier.com

linkinghub.elsevier.com

"Redirecting". linkinghub.elsevier.com.
"Redirecting". linkinghub.elsevier.com.
"Redirecting". linkinghub.elsevier.com.

fshdglobal.org

Global, FSHD. "The History of FSHD".

icmrs.net

"Professor Steve Wilton" (PDF).

mdaquest.org

Gurunathan, Sujatha (November 17, 2020). "Once a Wild Idea, Successful First-Generation Exon-Skipping Therapies Pave the Way for Personalized Treatments".

monash.edu

murdoch.edu.au

"Rewriting the rules for rare diseases". www.murdoch.edu.au.
"Working together to solve global health challenges through the precision medicine revolution" (PDF).
"Genetic researcher shares insights on TEDxPerth". www.murdoch.edu.au.
"Pioneering treatments for Duchenne muscular dystrophy". Research - Health Futures Institute.
"WA scientists recognised for life changing hat trick". www.murdoch.edu.au.
"Medical breakthrough wins Eureka Prize". www.murdoch.edu.au.

musculardystrophynews.com

Santos, Isaura (November 7, 2014). "Almost $800,000 To Develop Genetic Drugs For DMD, Other Rare Diseases Awarded To Murdoch University". musculardystrophynews.com.

nature.com

Lu, Qi Long; Mann, Christopher J.; Lou, Fang; Bou-Gharios, George; Morris, Glenn E.; Xue, Shao-an; Fletcher, Sue; Partridge, Terence A.; Wilton, Stephen D. (August 3, 2003). "Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse". Nature Medicine. 9 (8): 1009–1014. doi:10.1038/nm897 – via www.nature.com.
Alter, Julia; Lou, Fang; Rabinowitz, Adam; Yin, HaiFang; Rosenfeld, Jeffrey; Wilton, Steve D.; Partridge, Terence A.; Lu, Qi Long (February 3, 2006). "Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology". Nature Medicine. 12 (2): 175–177. doi:10.1038/nm1345. PMID 16444267 – via www.nature.com.

nih.gov

ncbi.nlm.nih.gov

Cale, Jessica M.; Greer, Kane; Fletcher, Sue; Wilton, Steve D. (January 3, 2021). "Proof-of-Concept: Antisense Oligonucleotide Mediated Skipping of Fibrillin-1 Exon 52". International Journal of Molecular Sciences. 22 (7): 3479. doi:10.3390/ijms22073479. PMC 8037683.
Li, Dunhui; Aung-Htut, May T.; Ham, Kristin A.; Fletcher, Sue; Wilton, Steve D. (January 3, 2020). "A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations". International Journal of Molecular Sciences. 21 (19): 7282. doi:10.3390/ijms21197282. PMC 7582384. PMID 33019779.

pubmed.ncbi.nlm.nih.gov

Li, Dunhui; Aung-Htut, May T.; Ham, Kristin A.; Fletcher, Sue; Wilton, Steve D. (January 3, 2020). "A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations". International Journal of Molecular Sciences. 21 (19): 7282. doi:10.3390/ijms21197282. PMC 7582384. PMID 33019779.
Alter, Julia; Lou, Fang; Rabinowitz, Adam; Yin, HaiFang; Rosenfeld, Jeffrey; Wilton, Steve D.; Partridge, Terence A.; Lu, Qi Long (February 3, 2006). "Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology". Nature Medicine. 12 (2): 175–177. doi:10.1038/nm1345. PMID 16444267 – via www.nature.com.

oup.com

academic.oup.com

"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse".

perroninstitute.org

"Our people - Perron Institute". www.perroninstitute.org. October 26, 2021.
"Molecular Therapies - Perron Institute". www.perroninstitute.org.
"Perron Institute Director Steve Wilton WA of the Year award finalist". www.perroninstitute.org. May 14, 2016.
"Professor Steve Wilton AO - Perron Institute". www.perroninstitute.org.

rotarymastertonsouth.club

"Club Services | The Rotary Club of Masterton South".

rotarywestperth.org.au

"Club History | Rotary Club of West Perth".

scholar.google.com

"Steve Wilton". scholar.google.com.

sciencedirect.com

"Antisense Oligonucleotide-induced Exon Skipping Across the Human Dystrophin Gene Transcript - ScienceDirect".

thelancet.com

thewest.com.au

"Praise for life's work fighting muscular dystrophy". The West Australian. June 13, 2021.
"Meet Billy — the 16yo walking, talking miracle". The West Australian. April 29, 2017.

uwa.edu.au

news.uwa.edu.au

"Breakthrough for boys who can't walk shortlisted for WA Innovation Award : Archive Page : The University of Western Australia". www.news.uwa.edu.au.
"Worldwide patent opens doors to treatment of muscular dystrophy : Archive Page : The University of Western Australia". www.news.uwa.edu.au.

research-repository.uwa.edu.au

"Steve Wilton". the UWA Profiles and Research Repository.